{
  "first_published_at": "2013-08-07", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300406", 
  "title": "Diclofenac: public consultation on availability as a Pharmacy medicine", 
  "tags": "{\"parsed_therapeutic\": [\"pain-management-palliation\"], \"Therapeutic area:\": [\"Pain management and palliation\"]}", 
  "_document_number": 58, 
  "label": null, 
  "icon": null, 
  "therapeutic_area": [
    "pain-management-palliation"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Diclofenac: public consultation on availability as a Pharmacy medicine</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: August 2013</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We have launched a public consultation on the continued availability of oral diclofenac as a Pharmacy (P) medicine-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We have launched a public consultation on the continued availability of&#160;oral diclofenac as a Pharmacy (P) medicine and in particular on risk-minimisation measures advised by the Commission on Human Medicines.</p>\n\n<p>Any comments can be emailed to: <a href=\"mailto:%20reclassification@mhra.gsi.gov.uk\">reclassification@mhra.gsi.gov.uk</a>; alternatively they may be addressed to: Colette McCreedy, Self Medication Specialist and Unit Manager, MHRA, 3rd Floor, 151 Buckingham Palace Road, London SW1W 9SZ.</p>\n\n<p>Comments must arrive no later than Oct 28, 2013 to be taken into account.</p>\n\n<p>Further information can be found <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON300361\">here</a></p>\n\n<p>The most recent safety advice for diclofenac can be found <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON286975\">here</a></p>\n\n<p>&#160;</p>\n\n<p><em>Article citation: Drug Safety Update vol 7 issue 1, August 2013: O2.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We have launched a public consultation on the continued availability of&#160;oral diclofenac as a Pharmacy (P) medicine and in particular on risk-minimisation measures advised by the Commission on Human Medicines.</p>\n\n<p>Any comments can be emailed to: <a href=\"mailto:%20reclassification@mhra.gsi.gov.uk\">reclassification@mhra.gsi.gov.uk</a>; alternatively they may be addressed to: Colette McCreedy, Self Medication Specialist and Unit Manager, MHRA, 3rd Floor, 151 Buckingham Palace Road, London SW1W 9SZ.</p>\n\n<p>Comments must arrive no later than Oct 28, 2013 to be taken into account.</p>\n\n<p>Further information can be found <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON300361\">here</a></p>\n\n<p>The most recent safety advice for diclofenac can be found <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON286975\">here</a></p>\n\n<p>&#160;</p>\n\n<p><em>Article citation: Drug Safety Update vol 7 issue 1, August 2013: O2.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2013-08-01", 
  "date_last_modified": "2013-08-07", 
  "_assets": [], 
  "_item_id": 58, 
  "summary": "", 
  "body": "Article date: August 2013\n\nWe have launched a public consultation on the continued availability of oral diclofenac as a Pharmacy (P) medicine and in particular on risk-minimisation measures advised by the Commission on Human Medicines.\n\nAny comments can be emailed to: [reclassification@mhra.gsi.gov.uk](mailto:%20reclassification@mhra.gsi.gov.uk); alternatively they may be addressed to: Colette McCreedy, Self Medication Specialist and Unit Manager, MHRA, 3rd Floor, 151 Buckingham Palace Road, London SW1W 9SZ.\n\nComments must arrive no later than Oct 28, 2013 to be taken into account.\n\nFurther information can be found [here](http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON300361)\n\nThe most recent safety advice for diclofenac can be found [here](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON286975)\n\n \n\nArticle citation: Drug Safety Update vol 7 issue 1, August 2013: O2.\n"
}